In response to the news, the broker has put a speculative buy rating and 35 cents price target on the uranium developer's ...

This ASX stock is having a strong session despite the market weakness. Here's the big news giving its shares a ...

Analysts at Bell Potter see significant value on offer from this blue chip. The post Why this ASX 200 stock could rise 40%+ ...

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

I think this stock could be a leading buy for income today. The post I rate this ASX dividend stock as a top buy right now ...

US stock indexes are rising  as Wall Street waits to hear what Federal Reserve Jerome Powell has to say after the central ...

ASX took a dip after US futures slid and Israel’s airstrikes rattled nerves, while gold hit a new high, New Hope coal soared.

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock ...

Most readers would already be aware that EVT's (ASX:EVT) stock increased significantly by 19% over the past three months. However, we wonder if the company's inconsistent financials would have any ...

Two influential governance advisers have backed a hedge fund-instigated vote that would force the miner to assess collapsing ...